|4Jun 19, 5:19 PM ET

MEDIMMUNE INC /DE 4

4 · MEDIMMUNE INC /DE · Filed Jun 19, 2007

Insider Transaction Report

Form 4
Period: 2007-06-18
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1825,0000 total
    Exercise: $27.12Exp: 2016-06-30Common Stock (25,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2007-06-1830,0000 total
    Exercise: $24.04Exp: 2009-06-30Common Stock (30,000 underlying)
Footnotes (7)
  • [F1]This option, which provided for vesting in four equal annual installments beginning on 06/30/2000, was cancelled pursuant to the merger agreement between the issuer and AstraZeneca PLC in exchange for a cash payment of $33.96, representing the difference between the exercise price of the option and $58.00 per share.
  • [F2]This option, which provided for vesting in four equal annual installments beginning on 06/30/2002, was cancelled in the merger in exchange for a cash payment of $10.80 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F3]This option, which provided for vesting in four equal annual installments beginning on 06/30/2003, was cancelled in the merger in exchange for a cash payment of $31.60 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F4]This option, which provided for vesting in four equal annual installments beginning on 06/30/2004, was cancelled in the merger in exchange for a cash payment of $22.16 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F5]This option, which provided for vesting in four equal annual installments beginning on 06/30/2005, was cancelled in the merger in exchange for a cash payment of $34.83 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F6]This option, which provided for vesting in four equal annual installments beginning on 06/30/2006, was cancelled in the merger in exchange for a cash payment of $30.88 per share, representing the difference between the exercise price of the option and $58.00 per share.
  • [F7]This option, which provided for vesting in four equal annual installments beginning on 06/30/2007, was cancelled in the merger in exchange for a cash payment of $30.88 per share, representing the difference between the exercise price of the option and $58.00 per share.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT